Skip to main content
. 2019 Mar 18;34(3):e201900309. doi: 10.1590/s0102-865020190030000009

Table 1. Comparison of demographics between groupsa.

Total AM PM p
Age, Mean±SD (Median) 72.5±7.8 (72) 73.1±7.8 (72) 71.6±8.1 (70) 0.171
Gender Male, n(%) 130 (61.6) 68 (59.1) 62 (64.6) 0.417
Female, n(%) 81 (38.4) 47 (40.9) 34 (35.4)
BMI, Mean±SD (Median) 28.0±4.0(28.1) 28±4.2(28.1) 27.6±3.8 (28.1) 0.600
ASA ASA II, n(%) 135 (64) 78 (67.8) 57 (59.4) 0.203
ASA III, n(%) 76 (36) 37 (32.2) 39 (40.6)
Comorbidity None, n(%) 58 (27.5) 28 (24.3) 30 (31.3) 0.282
HT, n(%) 45 (21.3) 34 (29.6) 11 (11.5)
DM, n(%) 6 (2.8) 1 (0.9) 5 (5.2)
IHD, n(%) 13 (6.2) 8 (7) 5 (5.2)
COPD, n(%) 9 (4.3) 4 (3.5) 5 (5.2)
CHF, n(%) 3 (1.4) 2 (1.7) 1 (1)
Multiple, n(%) 77 (36.5) 38 (33) 39 (40.6)
Operation type THR, n(%) 51 (24.2) 30 (26.1) 21 (21.9) 0.135
TKR, n(%) 47 (22.3) 32 (27.8) 15 (15.6)
TUR-BT, n(%) 58 (27.5) 29 (25.2) 29 (30.2)
TUP-P, n(%) 33 (15.6) 14 (12.2) 19 (19.8)
URS, n(%) 22 (10.4) 10 (8.7) 12 (12.5)
Hydration amount (ml) 486.3±290.6 (300) 490.9±290.9 (300) 480.7±291.7 (300) 0.812
Amount of spinal anesthetic (ml) 2.4±0.5 (2.5) 2.4±0.5(2.5) 2.4±0.4 (2.5) 0.835
Level of sensorial blockade T6, n(%) 52 (24.6) 30 (26.1) 22 (22.9) 0.239
T7, n(%) 24 (11.5) 13 (11.3) 11 (11.5)
T8, n(%) 57 (27.0) 28 (24.3) 29 (30.2)
T9, n(%) 33 (15.6) 14 (12.2) 19 (19.8)
T10, n(%) 45 (21.3) 30 (26.1) 15 (15.6)

a. (HT: Hypertension, DM: Diabetes mellitus, IHD: Ischemic heart disease, COPD: Chronic obstructive pulmonary disease, CHF: Congestive Heart Failure ,THR: Total hip replacement surgery, TKR: Total knee replacement surgery, TUR-BT: Transuretheral resection of bladder tumours, TUR-P: Transuretheral resection of the prostate, BMI: body mass index, URS: Ureterorenoscopy for ureterolithiasis).